They demonstrated the proportion of TIM3+FOXP3+ Tregs, which could potently suppress IFN‐γ and TNF‐α inflammation from Teffs by producing high IL‐10 and TGF‐β, was significantly decreased in patients with RA. This evidence concerns the gene TGFB1 and rheumatoid arthritis.